AIRS
AirSculpt Technologies, Inc.
Medical - Care Facilities
Market Cap$216M
5Y Perf.-78.2%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
AIRS vs ESTA vs SKIN vs INMD
Revenue, margins, valuation, and 5-year total return — side by side.
ESTA
Establishment Labs Holdings Inc.
Medical - Devices
Market Cap$2.12B
5Y Perf.-11.7%
SKIN
The Beauty Health Company
Household & Personal Products
Market Cap$118M
5Y Perf.-96.7%
INMD
InMode Ltd.
Medical - Devices
Market Cap$882M
5Y Perf.-85.3%
AIRS vs ESTA vs SKIN vs INMD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AIRS | ESTA | SKIN | INMD |
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Devices | Household & Personal Products | Medical - Devices |
| Market Cap | $216M | $2.12B | $118M | $882M |
| Revenue (TTM) | $158M | $211M | $296M | $375M |
| Net Income (TTM) | $-18M | $-51M | $-6M | $87M |
| Gross Margin | 64.0% | 69.3% | 64.9% | 77.8% |
| Operating Margin | -9.3% | -18.5% | -3.6% | 21.3% |
| Forward P/E | — | — | — | 9.6x |
| Total Debt | $105M | $264M | $379M | $13M |
| Cash & Equiv. | $8M | $76M | $233M | $303M |
AIRS vs ESTA vs SKIN vs INMD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AIRS
ESTA
SKIN
INMD
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| AirSculpt Technolog… (AIRS) | 100 | 21.8 | -78.2% |
| Establishment Labs … (ESTA) | 100 | 88.3 | -11.7% |
| The Beauty Health C… (SKIN) | 100 | 3.3 | -96.7% |
| InMode Ltd. (INMD) | 100 | 14.7 | -85.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AIRS vs ESTA vs SKIN vs INMD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: INMD leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Establishment Labs Holdings Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. AIRS and SKIN also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AIRS
AirSculpt Technologies, Inc.
The Income Pick
AIRS is the clearest fit if your priority is dividends.
- 0.1% yield; the other 3 pay no meaningful dividend
Best for: dividends
ESTA
Establishment Labs Holdings Inc.
The Growth Play
ESTA is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 27.1%, EPS growth 42.7%, 3Y rev CAGR 9.3%
- 191.0% 10Y total return vs INMD's 105.0%
- 27.1% revenue growth vs SKIN's -10.0%
- +116.5% vs SKIN's -35.9%
Best for: growth exposure and long-term compounding
SKIN
The Beauty Health Company
The Value Play
SKIN is the clearest fit if your priority is value.
- Better valuation composite
Best for: value
INMD
InMode Ltd.
The Income Pick
INMD carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 1.04
- Lower volatility, beta 1.04, Low D/E 1.9%, current ratio 9.88x
- Beta 1.04, current ratio 9.88x
- 23.3% margin vs ESTA's -24.2%
Best for: income & stability and sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ESTA | 27.1% revenue growth vs SKIN's -10.0% |
| Value | SKIN | Better valuation composite |
| Quality / Margins | INMD | 23.3% margin vs ESTA's -24.2% |
| Stability / Safety | INMD | Beta 1.04 vs AIRS's 3.37, lower leverage |
| Dividends | AIRS | 0.1% yield; the other 3 pay no meaningful dividend |
| Momentum (1Y) | ESTA | +116.5% vs SKIN's -35.9% |
| Efficiency (ROA) | INMD | 11.8% ROA vs ESTA's -15.0%, ROIC 13.5% vs -14.6% |
AIRS vs ESTA vs SKIN vs INMD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
Segment breakdown not available.
FY 2025
FY 2025
AIRS vs ESTA vs SKIN vs INMD — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLINMDLAGGINGSKIN
Who Leads Where
INMD leads in 2 of 6 categories
ESTA leads 1 • AIRS leads 0 • SKIN leads 0 • 2 tied
Explore the data ↓SKINThe Beauty Health Com…
0leads
AIRSAirSculpt Technologie…
0leads
ESTAEstablishment Labs Ho…
1leads
INMDInMode Ltd.
2leads
6 Total Categories
CATEGORYLEADERvs ESTAvs AIRSMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
INMD4/6
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
INMD7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
ESTA5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
INMD leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
INMD is the larger business by revenue, generating $375M annually — 2.4x AIRS's $158M. INMD is the more profitable business, keeping 23.3% of every revenue dollar as net income compared to ESTA's -24.2%. On growth, ESTA holds the edge at +45.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AIRSAirSculpt Technol… | ESTAEstablishment Lab… | SKINThe Beauty Health… | INMDInMode Ltd. |
|---|---|---|---|---|
| RevenueTrailing 12 months | $158M | $211M | $296M | $375M |
| EBITDAEarnings before interest/tax | -$2M | -$32M | $9M | $81M |
| Net IncomeAfter-tax profit | -$18M | -$51M | -$6M | $87M |
| Free Cash FlowCash after capex | $2M | -$57M | $29M | $91M |
| Gross MarginGross profit ÷ Revenue | +64.0% | +69.3% | +64.9% | +77.8% |
| Operating MarginEBIT ÷ Revenue | -9.3% | -18.5% | -3.6% | +21.3% |
| Net MarginNet income ÷ Revenue | -11.4% | -24.2% | -2.0% | +23.3% |
| FCF MarginFCF ÷ Revenue | +1.6% | -27.2% | +9.8% | +24.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -17.8% | +45.2% | -6.7% | +5.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -50.0% | +92.6% | +38.0% | -30.8% |
INMD leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
Evenly matched — SKIN and INMD each lead in 2 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, INMD's 6.9x EV/EBITDA is more attractive than SKIN's 7331.2x.
| Metric | AIRSAirSculpt Technol… | ESTAEstablishment Lab… | SKINThe Beauty Health… | INMDInMode Ltd. |
|---|---|---|---|---|
| Market CapShares × price | $216M | $2.1B | $118M | $882M |
| Enterprise ValueMkt cap + debt − cash | $313M | $2.3B | $264M | $593M |
| Trailing P/EPrice ÷ TTM EPS | -24.71x | -41.88x | -5.69x | 9.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 9.64x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.98x |
| EV / EBITDAEnterprise value multiple | 31.06x | — | 7331.15x | 6.88x |
| Price / SalesMarket cap ÷ Revenue | 1.20x | 10.03x | 0.39x | 2.38x |
| Price / BookPrice ÷ Book value/share | 2.52x | 90.61x | 2.02x | 1.33x |
| Price / FCFMarket cap ÷ FCF | — | — | 3.17x | 10.46x |
Evenly matched — SKIN and INMD each lead in 2 of 5 comparable metrics.
Profitability & Efficiency
INMD leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
INMD delivers a 13.3% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-2 for ESTA. INMD carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ESTA's 11.23x. On the Piotroski fundamental quality scale (0–9), SKIN scores 7/9 vs AIRS's 2/9, reflecting strong financial health.
| Metric | AIRSAirSculpt Technol… | ESTAEstablishment Lab… | SKINThe Beauty Health… | INMDInMode Ltd. |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -21.8% | -2.0% | -9.4% | +13.3% |
| ROA (TTM)Return on assets | -9.0% | -15.0% | -1.2% | +11.8% |
| ROICReturn on invested capital | -0.8% | -14.6% | -6.8% | +13.5% |
| ROCEReturn on capital employed | -1.0% | -14.1% | -4.5% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 7 | 3 |
| Debt / EquityFinancial leverage | 1.32x | 11.23x | 6.20x | 0.02x |
| Net DebtTotal debt minus cash | $97M | $189M | $146M | -$289M |
| Cash & Equiv.Liquid assets | $8M | $76M | $233M | $303M |
| Total DebtShort + long-term debt | $105M | $264M | $379M | $13M |
| Interest CoverageEBIT ÷ Interest expense | -1.82x | -1.30x | 0.81x | — |
INMD leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
ESTA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ESTA five years ago would be worth $10,061 today (with dividends reinvested), compared to $707 for SKIN. Over the past 12 months, ESTA leads with a +116.5% total return vs SKIN's -35.9%. The 3-year compound annual growth rate (CAGR) favors ESTA at 2.1% vs SKIN's -56.4% — a key indicator of consistent wealth creation.
| Metric | AIRSAirSculpt Technol… | ESTAEstablishment Lab… | SKINThe Beauty Health… | INMDInMode Ltd. |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +87.0% | +4.6% | -35.0% | -5.9% |
| 1-Year ReturnPast 12 months | +35.2% | +116.5% | -35.9% | -2.1% |
| 3-Year ReturnCumulative with dividends | -34.0% | +6.4% | -91.7% | -60.2% |
| 5-Year ReturnCumulative with dividends | -75.6% | +0.6% | -92.9% | -63.9% |
| 10-Year ReturnCumulative with dividends | -75.6% | +191.0% | -91.6% | +105.0% |
| CAGR (3Y)Annualised 3-year return | -12.9% | +2.1% | -56.4% | -26.4% |
ESTA leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — ESTA and INMD each lead in 1 of 2 comparable metrics.
Risk & Volatility
INMD is the less volatile stock with a 1.04 beta — it tends to amplify market swings less than AIRS's 3.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ESTA currently trades 86.5% from its 52-week high vs AIRS's 28.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AIRSAirSculpt Technol… | ESTAEstablishment Lab… | SKINThe Beauty Health… | INMDInMode Ltd. |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.37x | 1.30x | 2.00x | 1.04x |
| 52-Week HighHighest price in past year | $12.00 | $83.31 | $2.69 | $16.74 |
| 52-Week LowLowest price in past year | $1.51 | $32.75 | $0.76 | $12.72 |
| % of 52W HighCurrent price vs 52-week peak | +28.8% | +86.5% | +33.8% | +83.2% |
| RSI (14)Momentum oscillator 0–100 | 70.0 | 66.8 | 52.1 | 39.8 |
| Avg Volume (50D)Average daily shares traded | 3.1M | 455K | 760K | 804K |
Evenly matched — ESTA and INMD each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AIRS as "Hold", ESTA as "Buy", SKIN as "Hold", INMD as "Buy". Consensus price targets imply 73.4% upside for AIRS (target: $6) vs 14.9% for INMD (target: $16). AIRS is the only dividend payer here at 0.13% yield — a key consideration for income-focused portfolios.
| Metric | AIRSAirSculpt Technol… | ESTAEstablishment Lab… | SKINThe Beauty Health… | INMDInMode Ltd. |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $6.00 | $85.00 | $1.30 | $16.00 |
| # AnalystsCovering analysts | 5 | 14 | 13 | 11 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | — |
| Dividend / ShareAnnual DPS | $0.00 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% | 0.0% | +14.5% |
Insufficient data to determine a leader in this category.
Key Takeaway
INMD leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ESTA leads in 1 (Total Returns). 2 tied.
Best OverallInMode Ltd. (INMD)Leads 2 of 6 categories
Loading custom metrics...
AIRS vs ESTA vs SKIN vs INMD: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is AIRS or ESTA or SKIN or INMD a better buy right now?
For growth investors, Establishment Labs Holdings Inc.
(ESTA) is the stronger pick with 27. 1% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). InMode Ltd. (INMD) offers the better valuation at 9. 7x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Establishment Labs Holdings Inc. (ESTA) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AIRS or ESTA or SKIN or INMD?
Over the past 5 years, Establishment Labs Holdings Inc.
(ESTA) delivered a total return of +0. 6%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: ESTA returned +191. 0% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AIRS or ESTA or SKIN or INMD?
By beta (market sensitivity over 5 years), InMode Ltd.
(INMD) is the lower-risk stock at 1. 04β versus AirSculpt Technologies, Inc. 's 3. 37β — meaning AIRS is approximately 224% more volatile than INMD relative to the S&P 500. On balance sheet safety, InMode Ltd. (INMD) carries a lower debt/equity ratio of 2% versus 11% for Establishment Labs Holdings Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AIRS or ESTA or SKIN or INMD?
By revenue growth (latest reported year), Establishment Labs Holdings Inc.
(ESTA) is pulling ahead at 27. 1% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -77. 4% for AirSculpt Technologies, Inc.. Over a 3-year CAGR, AIRS leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AIRS or ESTA or SKIN or INMD?
InMode Ltd.
(INMD) is the more profitable company, earning 25. 3% net margin versus -24. 2% for Establishment Labs Holdings Inc. — meaning it keeps 25. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INMD leads at 23. 0% versus -18. 5% for ESTA. At the gross margin level — before operating expenses — INMD leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is AIRS or ESTA or SKIN or INMD more undervalued right now?
Analyst consensus price targets imply the most upside for AIRS: 73.
4% to $6. 00.
07Which pays a better dividend — AIRS or ESTA or SKIN or INMD?
In this comparison, AIRS (0.
1% yield) pays a dividend. ESTA, SKIN, INMD do not pay a meaningful dividend and should not be held primarily for income.
08Is AIRS or ESTA or SKIN or INMD better for a retirement portfolio?
For long-horizon retirement investors, InMode Ltd.
(INMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 04), +105. 0% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INMD: +105. 0%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AIRS and ESTA and SKIN and INMD?
These companies operate in different sectors (AIRS (Healthcare) and ESTA (Healthcare) and SKIN (Consumer Defensive) and INMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AIRS is a small-cap quality compounder stock; ESTA is a small-cap high-growth stock; SKIN is a small-cap quality compounder stock; INMD is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(AIRS: -17.8% · ESTA: 45.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.